SharesGrow 7-Criteria Score
All 7 criteria scored · valuation-related highlighted on this page
Endexx Corporation (EDXC) .
Criteria proven by this page:
- VALUE (0/100, Fail) — the composite valuation score falls below the 60/100 threshold required to pass.
Overall SharesGrow Score: 27/100 with 1/7 criteria passed.
SharesGrow 7-Criteria Score
✗
HEALTH
0/100
Debt-to-Equity & liquidity
→ Health
Valuation Snapshot — EDXC
Valuation Multiples
P/E (TTM)0.0
Forward P/EN/A
PEG RatioN/A
Forward PEGN/A
P/B Ratio0.00
P/S Ratio0.03
EV/EBITDA0.0
Per Share Data
EPS (TTM)$-0.01
Book Value / Share$0.00
Revenue / Share$0.00
FCF / Share$0.00
Yields & Fair Value
Earnings YieldN/A
Dividend Yield0.00%
P/E Ratio & Earnings Yield
Earnings Per Share (EPS) History
| Year |
EPS (Diluted) |
Revenue |
Net Income |
Net Margin |
| 2015 |
$-0.01 |
$126.26K |
$-1.17M |
-926.2% |
| 2016 |
$0.00 |
$220.76K |
$-776.66K |
-351.8% |
| 2017 |
$0.00 |
$418.39K |
$-668.73K |
-159.8% |
| 2018 |
$-0.01 |
$797.55K |
$-1.74M |
-217.9% |
| 2019 |
$-0.03 |
$1.5M |
$-11.39M |
-760.3% |
| 2020 |
$-0.03 |
$1.97M |
$-11.19M |
-567.9% |
| 2021 |
$-0.02 |
$650.52K |
$-7.76M |
-1192.7% |
| 2022 |
$-0.01 |
$1.28M |
$-4.9M |
-383.2% |
| 2023 |
$-0.01 |
$3.91M |
$-6.5M |
-166.3% |
| 2024 |
$-0.01 |
$1.66M |
$-3.4M |
-205.2% |